Media News

BRAND’S® ESSENCE OF CHICKEN STRENGTHENS “KEKAL CERGAS & SELAMAT” CAMPAIGN WITH PLUS HIGHWAY FOR THE THIRD YEAR, WELCOMES MIROS IN ROAD SAFETY MISSION

-  BRAND'S® Essence of Chicken Powers Safer Journeys—Helping Drivers Combat Fatigue, a Leading Cause of Road Accidents, and Stay Alert on the Road at PLUS R&Rs KUALA LUMPUR, Malaysia, March 19, 2025 /PRNewswire/ -- BRAND'S® Essence of Chicken (BRAND'S) continues its collaboration for the third consecutive year with PLUS Malaysia Berhad (PLUS) and, for the first time, the Malaysian Institute...

TPIsoftware and Yuan’s General Hospital Join Forces to Revolutionize Healthcare with GenAI Digital Health Platform

TAIPEI, March 19, 2025 /PRNewswire/ -- TPIsoftware (TWSE: 7781) and Yuan's General Hospital, a leading medical institution in Southern Taiwan, have collaborated to launch a digital health platform that leverages generative AI technology to facilitate data transformation and streamline data exchange within hospital information systems (HIS), enhancing operational efficiency with automated medical processes....

Advancing Artificial Intelligence (AI) in medicine: New AI Institute launched to drive healthcare innovation; MOU inked to reinforce strong governance

The Artificial Intelligence in Medicine Institute (AIMI) will focus on: Cutting edge AI research and integration into different medical specialties. Ensuring safe, responsible AI adoption, emphasising patient safety and data privacy. Promoting AI education for healthcare professionals and the public  Collaborating with industry partners to drive commercialisation of AI innovations. ...

Innovent and HUTCHMED Jointly Announce that the FRUSICA-2 Phase 2/3 Study of Sintilimab and Fruquintinib Combination Has Met Its Primary Endpoint in Advanced Renal Cell Carcinoma in China

SAN FRANCISCO and SUZHOU, China, March 19, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, and HUTCHMED (China) Limited ("HUTCHMED") (Nasdaq/AIM:HCM; HKEX:13), today jointly announce that the FRUSICA-2 Phase 2/3 clinical trial evaluating...

CARsgen Announced 2024 Annual Results

SHANGHAI, March 19, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced its 2024 Annual Results. Business Highlights Zevor-cel was approved by China's National Medical Products Administration (NMPA). As of December 31, 2024, certification and filings for zevor-cel completed in 23...

DarwinHealth Recognized and Honored as One of the Top 10 Most Innovative Biotech Companies: Named to Fast Company’s Prestigious Annual List of the World’s Most Innovative Companies of 2025

NEW YORK, March 19, 2025 /PRNewswire/ -- DarwinHealth is proud to have been named to Fast Company's prestigious list of the World's Most Innovative Companies of 2025. This year's list shines a spotlight on businesses that are shaping research, industry, and the human condition through their unique innovations in artificial intelligence and other...

Lunit Secures Multi-Year Contract with UAE’s Largest Healthcare Network to Power National AI Breast Cancer Screening Program

Strategic agreement to deploy Lunit INSIGHT MMG across SEHA's extensive healthcare network, analyzing over hundred thousand mammograms over five years SEOUL, South Korea, March 18, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced that it has signed a multi-year contract with Abu...

Vatech and Pearl Join Forces to Revolutionize Dental Diagnosis with AI Integration

HWASEONG, South Korea, March 18, 2025 /PRNewswire/ -- Vatech, a global leader in dental imaging solutions, and Pearl, a frontrunner in dental AI technology, have announced a collaborative alliance aimed at transforming the landscape of dental diagnosis. By integrating Pearl's advanced AI-powered pathology detection capabilities into Vatech's diagnostic software, dental professionals worldwide...

Bloomage Passes GMP Audit by South Korea’s MFDS, Strengthening its Global Quality Assurance

PARSIPPANY, NJ., March 18, 2025 /PRNewswire/ -- Bloomage, a global leader in hyaluronic acid and other bioactive substance innovations, has successfully passed the GMP on-site inspection by South Korea's Ministry of Food and Drug Safety (MFDS) with no observations of non-compliance. This certification reinforces Bloomage's commitment to quality assurance of pharmaceutical-grade products, ensuring compliance with South Korea's stringent regulatory...

SOPHiA GENETICS Announces Two Million Patient Cases Analyzed, Marking a New Milestone for Data-Driven Medicine at NVIDIA GTC

BOSTON, MA and ROLLE, Switzerland, March 18, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and leader in data-driven medicine, has reached a historic milestone: more than two million patients genomic profiles analyzed on the AI-powered analytics Platform SOPHiA DDM™. This achievement solidifies SOPHiA GENETICS as the gold-standard provider...